Maria Grazia Viganò

Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma

Vanesa Gregorc, Paolo Andrea Zucali, Armando Santoro et al. · Journal of Clinical Oncology · 2010 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma

Simona Bossolasco, Paola Cinque, Maurilio Ponzoni et al. · Journal of NeuroVirology · 2002 · 75 citations

Life Sciences, Infectious Diseases, Oncology +11

Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study

Alessandro Morabito, Vittorio Gebbia, Massimo Di Maïo et al. · Lung Cancer · 2013 · 56 citations

Medicine, Oncology, Chemotherapy +12

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Monica Giovannini, Vanesa Gregorc, Carmen Belli et al. · Journal of Oncology · 2009 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17